Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study

ABSTRACT Type 2 diabetes mellitus (T2DM) increases fracture risk despite normal or increased BMD. Abaloparatide reduces fracture risk in patients with postmenopausal osteoporosis (PMO); however, its efficacy in women with T2DM is unknown. This post hoc analysis evaluated the efficacy and safety of a...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Ruban Dhaliwal, Didier Hans, Gary Hattersley, Bruce Mitlak, Lorraine A Fitzpatrick, Yamei Wang, Ann V Schwartz, Paul D Miller, Robert G Josse
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Oxford University Press 2020-04-01
Schriftenreihe:	JBMR Plus
Schlagworte:	ABALOPARATIDE ANABOLICS BONE MINERAL DENSITY CLINICAL TRIALS DXA FRACTURE PREVENTION
Online-Zugang:	https://doi.org/10.1002/jbm4.10346
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!